Left Atrial Appendage Closure With SentreHeart Lariat® Device

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Cardioembolic StrokeAtrial Fibrillation
Interventions
PROCEDURE

Left atrial appendage closure

The SentreHeart Lariat® device (that is approved for soft tissue ligation) will be used to ligate or close the left atrial appendage as a stand-alone procedure at the participating centers.

DEVICE

SentreHeart Lariat®

The SentreHeart Lariat® device (that is approved for soft tissue ligation) will be used to ligate or close the left atrial appendage as a stand-alone procedure at the participating centers.

Trial Locations (1)

75093

Baylor Research Institute at The Heart Hospital Baylor Plano, Plano

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER